Medicofarma Biotech SA

Equities

MDB

PLINBOK00010

Biotechnology & Medical Research

End-of-day quote Warsaw S.E. Other stock markets 23:00:00 25/06/2024 BST			5-day change	1st Jan Change
0.55 ^PLN	-1.43%		-6.78%	-49.31%

05-13	Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-06	Medicofarma Biotech SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Medicofarma Biotech S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021

May 14, 2021 at 09:10 pm

Medicofarma Biotech S.A. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced operating income was PLN 103,143.96 compared to operating loss of PLN 127,893.74 a year ago. Net income was PLN 109,919.71 compared to net loss of PLN 133,006.41 a year ago.

Latest news about Medicofarma Biotech SA

Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Medicofarma Biotech SA Reports Earnings Results for the Full Year Ended December 31, 2023	02-06	CI
Medicofarma Biotech SA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-06	CI
Medicofarma Biotech SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Medicofarma Biotech SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Medicofarma Biotech SA Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	14/02/23	CI
Medicofarma Biotech SA Reports Earnings Results for the Full Year Ended December 31, 2022	14/02/23	CI
Medicofarma Biotech SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Medicofarma Biotech SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	01/08/22	CI
Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2022	12/05/22	CI
Medicofarma Biotech SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	04/02/22	CI
Medicofarma Biotech SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21	CI
Medicofarma Biotech Sa Reports Earnings Results for the Second Quarter Ended June 30, 2021	13/08/21	CI
Medicofarma Biotech S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	14/05/21	CI
INBOOK S.A. will Change its Name to Medicofarma Biotech S.A	19/02/21	CI
ABS Investment SA acquired 5.4% stake in Inbook Spólka Akcyjna from INVESTcon GROUP Spolka Akcyjna, Asset Management Arm.	01/03/16	CI
ABS Investment SA acquired 3.4% stake in Inbook Spólka Akcyjna.	29/11/15	CI
Slawomir Jarosz acquired 13.12% stake in Inbook Spólka Akcyjna.	09/10/14	CI

Chart Medicofarma Biotech SA

Duration

Period

More charts

Company Profile

Medicofarma Biotech SA, formerly InBook SA, is a Poland-based biotechnology company. It is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MEDICOFARMA BIOTECH SA	-49.31%	9.44M
MODERNA, INC.	+23.13%	52.73B
LONZA GROUP AG	+37.49%	39B
IQVIA HOLDINGS INC.	-8.73%	38.52B
ALNYLAM PHARMACEUTICALS, INC.	+28.09%	30.38B
CELLTRION, INC.	-12.26%	26.39B
ICON PUBLIC LIMITED COMPANY	+10.57%	26.08B
UNITED THERAPEUTICS CORPORATION	+45.05%	14.15B
MEDPACE HOLDINGS, INC.	+32.23%	12.6B
BIO-TECHNE CORPORATION	-6.56%	11.51B

Other Biotechnology & Medical Research